MP72 - MP72: Bladder Cancer: Non-invasive III

Poster Presenter(s)

• YB

  Yuto Baba
• GB

  Giorgio Bozzini, MD

  Humanitas Mater Domini
• 

  Nathan Brooks, MD

  The University of Texas MD Anderson Cancer Center

  PDF Poster Slides and Audio
• 

  Laura Bukavina, MD

  MD MPH
  Case Western/University Hospitals Cleveland Medical Center
• 

  Yu-Kuang Chen, MD

  Resident
  Taipei Veterans General Hospital

  PDF Poster Slides
• 

  Cosimo De Nunzio, MD,PhD

  Department of Urology, Ospedale Sant'andrea, Sapienza University

  PDF Poster Slides and Audio
• 

  Amr Elsawy

  Urology and Nephrology Center, Mansoura University, Mansoura-Egypt
• YH

  Yurie Hirata
• IJ

  Ilaria Jansen
• HK

  Hirotake Kodama
• YL

  Yuexin Liu
• RM

  Riccardo Mastroianni, MD

  "Sapienza" University

  PDF Poster Slides and Audio
• TM

  Tim Muilwijk
• 

  Ruchira Nandurkar

  Monash University

  PDF Poster Slides and Audio
• 

  Takahiro Nohara, PhD

  urology

  PDF Poster Slides and Audio
• MO

  Michael Oefelein, MD

  PDF Poster Slides
• TS

  Tetsuya Shindo, MD

  Sapporo Medical University School of Medicine

  PDF Poster Slides and Audio
• 

  Eugen Wang

  Center for Clinical Research, Region Sörmland, Uppsala University

  PDF Poster Slides and Audio

Presentations:

• 7:00 AM – 9:00 AM

  MP72-01: PHASE 1 OUTCOMES OF A NOVEL THIRD GENERATION LIPOSOMAL PACLITAXEL FORMULATION (TSD-001) IN LOW-INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS
  Michael G. Oefelein, MD
• 7:00 AM – 9:00 AM

  MP72-02: Re-examining the Depth of Invasion in High-Grade T1 Bladder Cancer and Clinical Outcomes:An Independent Predictor of Survival
  Laura Bukavina, MD
• 7:00 AM – 9:00 AM

  MP72-03: Assessing the impact of absence of detrusor muscle in Ta-LG urothelial carcinoma of the bladder on recurrence free survival
  Riccardo Mastroianni, MD
• 7:00 AM – 9:00 AM

  MP72-04: T1 substage in non-muscle invasive bladder urothelial carcinoma can predict progression free survival
  Yu-Kuang Chen, MD – Taipei Veterans General Hospital
• 7:00 AM – 9:00 AM

  MP72-05: Correlation between BMI and Outcomes in Patients Treated with BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer
  Nathan A. Brooks, MD
• 7:00 AM – 9:00 AM

  MP72-06: Thulium Laser en-bloc resection of bladder Tumor (THUEB-BT): TIGER (Thulium Italian Group Established on Research) study to compare laser and electrical en-bloc transurethral resection of bladder tumor
  Giorgio Bozzini, MD
• 7:00 AM – 9:00 AM

  MP72-07: Validation and modification of the EORTC risk tables to predict outcomes in non-muscle-invasive bladder cancer in Japanese patients
  Hirotake Kodama
• 7:00 AM – 9:00 AM

  MP72-08: Efficacy and safety of transurethral plasmakinetic enucleation of bladder tumor under obturator nerve block with the guidance of ultrasound and neurostimulation
  Yuexin Liu
• 7:00 AM – 9:00 AM

  MP72-09: Intraoperative Hypotension Caused by Oral Administration of 5-Aminolevulinic Acid for Photodynamic Diagnosis in Patients with Bladder Cancer
  Takahiro Nohara, PhD
• 7:00 AM – 9:00 AM

  MP72-10: The outcome of patients with high-risk non-muscle invasive bladder cancer in Sweden
  Eugen Wang – Center For Clinical Research, Region Sörmland, Upp
• 7:00 AM – 9:00 AM

  MP72-11: Optimal management for initially diagnosed Ta high grade bladder cancer. What does matter for intravesical recurrence ?
  Tetsuya Shindo, MD – Hakodate Goryoukaku Hospital
• 7:00 AM – 9:00 AM

  MP72-12: Luminal and Basal Immunohistochemical Markers in Papillary pTa Bladder Cancer: The Counterintuitive Role of CK5
  Tim Muilwijk
• 7:00 AM – 9:00 AM

  MP72-13: Performing Transurethral Resection Under General Anesthesia May Contribute to Higher Recurrence Rates in High Risk Non-Muscle Invasive Bladder Cancer
  Yuto Baba
• 7:00 AM – 9:00 AM

  MP72-14: Late recurrence of non-muscle-invasive bladder cancer after a 5-year cancer-free period
  Yurie Hirata
• 7:00 AM – 9:00 AM

  MP72-15: Safety evaluation of sequential Mitomycin and Bacillus Calmette-Guérin treatment versus Bacillus Calmette-Guérin monotherapy in patients with High risk Non-Muscle Invasive Bladder Cancer: MITOBCG study(EUDRACT Number 2017-004540-37)preliminary results
  Cosimo De Nunzio, MD,PhD
• 7:00 AM – 9:00 AM

  MP72-16: Detection and grading of bladder cancer on histological slides using deep learing
  Ilaria Jansen
• 7:00 AM – 9:00 AM

  MP72-17: Osmotic Cytolytic Effects Of Water On Cell Counts – Implications For Clinical Use Of Water Irrigation To Reduce Non-Muscle Invasive Bladder Cancer Recurrence
  Ruchira Nandurkar – Monash University
• 7:00 AM – 9:00 AM

  MP72-18: Diagnostic and Predictive Capacity of a Novel mRNA-based Urine Test (Xpert&[reg] Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer; Single Center Study
  Amr A. Elsawy